Panadol Osteo price hike statement ambiguous but not misleading: ACCC

By Lucy Cormack
Updated October 28 2016 - 11:08am, first published October 10 2016 - 2:45pm
The entrance into the market of generic paracetamol 665mg products was found to have an impact on sales of Panadol Osteo. Photo: Adam Hollingworth
The entrance into the market of generic paracetamol 665mg products was found to have an impact on sales of Panadol Osteo. Photo: Adam Hollingworth
The ACCC found statements about Panadol Osteo pricing were unlikely to establish a contravention of the Australian Consumer Law.
The ACCC found statements about Panadol Osteo pricing were unlikely to establish a contravention of the Australian Consumer Law.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options